Treatment strategies Pharmacotherapies that target the nAChRs, which mediate the reinforcing properties and neurocognitive effects of nicotine in smokers, may have therapeutic effects on neurocogni-tive dysfunction in schizophrenia.7,12 Several promising nAChR agents, including galantamine (an allosteric modulator of central nAChRs), DMXB-A (7-selective agonist), TC-5619 (a selective 42 nAChR agonist), and varenicline (42 partial agonist), have been studied in patients with schizophrenia.31-34 A recent study by Hong and colleagues35 found that varenicline treatment in stable, medication-compliant schizophrenia patients for 8 weeks (1 mg/d) improved sensory gating, startle reactivity, and executive function
This certification is the gold standard for athletes, ensuring the product is free from over 280 substances banned by major sporting organizations
Kitchen & Do-It-Yourselfers: Excellent for tiny welding jobs, igniting stoves, and caramelizing sugar
Freeman, T.D
A proud mom of three, she is thrilled to be making her New York City stage debut